Christian Ingvar

Christian Ingvar

Expert

Personal profile

Research

Translational research group involving Surgery, Oncology, Dermatology, Pathology, Epidemiology and Molecular biology. Studies focus on UV-radiation and tanning devices. The CDKN2A (unique Swedish founder mutation) described by our group gives a 70 % risk for melanoma with no specific phenotype. International collaboration via GenoMEL since 15 years with EU support. A new molecular subdivision of melanoma has been proposed by us where activation of pigmented and proliferative genes gives poor prognosis and immune genes good prognosis.  A prospective biobank (BioMEL) with epidemiological data, blood and tumour biopsies from every melanoma (primary and metastatic) focus on the development naevi to invasive melanoma. Treatment prediction of the new revolutionary treatments for metastatic melanoma with BRAF-inhibitors and immune modulators is also studied. The dermatoscopic appearance is compared to molecular biology.  LMSG is supported by CF, EU, LU, Region Skåne and several trusts.   

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

UKÄ subject classification

  • Medical and Health Sciences
  • Clinical Medicine

Fingerprint

Dive into the research topics where Christian Ingvar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or